Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doina Ivan

Showing results (131-140 of 140) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 140 results.
Cancers|June 1, 2019
Expression of PD-1 and PD-L1 in Extramammary Paget Disease: Implications for Immune-Targeted TherapyShakuntala H Mauzo, Michael T Tetzlaff, Denái R Milton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2016
Tumor Thickness and Mitotic Rate Robustly Predict Melanoma-Specific Survival in Patients with Primary Vulvar Melanoma: A Retrospective Review of 100 CasesPriyadharsini Nagarajan, Jonathan L Curry, Jing Ning, et al.
Journal of Cutaneous Pathology|April 19, 2016
Autoimmune dermatologic toxicities from immune checkpoint blockade with anti-PD-1 antibody therapy: a report on bullous skin eruptionsGeorge Jour, Isabella C Glitza, Rachel M Ellis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2018
Distinct Biological Types of Ocular Adnexal Sebaceous Carcinoma: HPV-Driven and Virus-Negative Tumors Arise through Nonoverlapping Molecular-Genetic AlterationsMichael T Tetzlaff, Jonathan L Curry, Jing Ning, et al.
Molecular Cancer Therapeutics|August 13, 2009
Activity of dasatinib against L576P KIT mutant melanoma: molecular, cellular, and clinical correlatesScott E Woodman, Jonathan C Trent, Katherine Stemke-Hale, et al.
Cancers|January 1, 2020
Aberrant DNA Methylation Predicts Melanoma-Specific Survival in Patients with Acral MelanomaDinesh Pradhan, George Jour, Denái Milton, et al.
Journal of Cutaneous Pathology|January 11, 2024
Nectin-4 expression in a subset of cutaneous adnexal carcinomas: A potential target for therapy with enfortumab vedotinWoo Cheal Cho, Rayan Saade, Priyadharsini Nagarajan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 7, 2019
Prognostic model for patient survival in primary anorectal mucosal melanoma: stage at presentation determines relevance of histopathologic featuresPriyadharsini Nagarajan, Jin Piao, Jing Ning, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 20, 2025
Corrigendum to "Prognostic Model for Patient Survival in Primary Anorectal Mucosal Melanoma: Stage at Presentation Determines Relevance of Histopathologic Features" [Modern Pathology 33 (2020) 496-513]Priyadharsini Nagarajan, Jin Piao, Jing Ning, et al.
The Journal of Investigative Dermatology|August 23, 2014
Beyond BRAF(V600): clinical mutation panel testing by next-generation sequencing in advanced melanomaAlan E Siroy, Genevieve M Boland, Denái R Milton, et al.
Pageof 14

Showing results (131-140 of 140) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 140 results.
Cancers|June 1, 2019
Expression of PD-1 and PD-L1 in Extramammary Paget Disease: Implications for Immune-Targeted TherapyShakuntala H Mauzo, Michael T Tetzlaff, Denái R Milton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2016
Tumor Thickness and Mitotic Rate Robustly Predict Melanoma-Specific Survival in Patients with Primary Vulvar Melanoma: A Retrospective Review of 100 CasesPriyadharsini Nagarajan, Jonathan L Curry, Jing Ning, et al.
Journal of Cutaneous Pathology|April 19, 2016
Autoimmune dermatologic toxicities from immune checkpoint blockade with anti-PD-1 antibody therapy: a report on bullous skin eruptionsGeorge Jour, Isabella C Glitza, Rachel M Ellis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2018
Distinct Biological Types of Ocular Adnexal Sebaceous Carcinoma: HPV-Driven and Virus-Negative Tumors Arise through Nonoverlapping Molecular-Genetic AlterationsMichael T Tetzlaff, Jonathan L Curry, Jing Ning, et al.
Molecular Cancer Therapeutics|August 13, 2009
Activity of dasatinib against L576P KIT mutant melanoma: molecular, cellular, and clinical correlatesScott E Woodman, Jonathan C Trent, Katherine Stemke-Hale, et al.
Cancers|January 1, 2020
Aberrant DNA Methylation Predicts Melanoma-Specific Survival in Patients with Acral MelanomaDinesh Pradhan, George Jour, Denái Milton, et al.
Journal of Cutaneous Pathology|January 11, 2024
Nectin-4 expression in a subset of cutaneous adnexal carcinomas: A potential target for therapy with enfortumab vedotinWoo Cheal Cho, Rayan Saade, Priyadharsini Nagarajan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 7, 2019
Prognostic model for patient survival in primary anorectal mucosal melanoma: stage at presentation determines relevance of histopathologic featuresPriyadharsini Nagarajan, Jin Piao, Jing Ning, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 20, 2025
Corrigendum to "Prognostic Model for Patient Survival in Primary Anorectal Mucosal Melanoma: Stage at Presentation Determines Relevance of Histopathologic Features" [Modern Pathology 33 (2020) 496-513]Priyadharsini Nagarajan, Jin Piao, Jing Ning, et al.
The Journal of Investigative Dermatology|August 23, 2014
Beyond BRAF(V600): clinical mutation panel testing by next-generation sequencing in advanced melanomaAlan E Siroy, Genevieve M Boland, Denái R Milton, et al.
Pageof 14